KSI kneat.com inc

Global Consumer Products Leader Selects Kneat to Digitize Validation

Global Consumer Products Leader Selects Kneat to Digitize Validation

LIMERICK, Ireland, Feb. 07, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a multinational consumer food and drink producer (“the Company”) has signed a three-year Master Services Agreement (“MSA”) with Kneat to digitize its validation processes.

Headquartered in Europe and operating manufacturing facilities globally, the Company will initially use Kneat for Equipment and Computer System Validation within a specialized health sciences division with over 5,000 employees.  The MSA allows the company to scale Kneat to all its affiliate companies and business divisions.

“Today's announcement highlights that life science applications for Kneat can be found outside traditional life sciences companies, as we bring another consumer products leader into the Kneat community. We are proud to be a part of this Company's world-class quality effort supporting their pursuit of health, wellness, and nutrition for people around the world.”

- Eddie Ryan, Chief Executive Officer of Kneat

The number of consumer goods companies relying on Kneat has grown over the past several years, as certain products in their portfolios are subject to validation regulatory requirements. Digitizing these processes helps these companies mitigate risk and protect the brands they have been building for years, and positions Kneat to continue adding value to their efforts over the years ahead.

About Kneat

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard.

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the use and implementation timelines of Kneat’s software within the customer’s validation processes, the ability and intent of the customer to scale the use of Kneat’s software within the customer’s organization, and the compliance of Kneat’s platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.

Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor’s own risk.

For further information:

Katie Keita, Kneat Investor Relations

P: 0

E:



EN
07/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on kneat.com inc

 PRESS RELEASE

Kneat Releases 2025 Annual Shareholder Letter Highlighting Resilience,...

Kneat Releases 2025 Annual Shareholder Letter Highlighting Resilience, Opportunities Presented by Artificial Intelligence LIMERICK, Ireland, Feb. 25, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today released its annual shareholder letter highlighting the durability of its growth over the course of a complex year for life sciences companies and the opportunities ahead. Dear Shareholders, As we look back on 2025, I want to begin by thanking you for your continued conf...

 PRESS RELEASE

Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025

Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025 Leadership Position Reinforced with Highest-Ever New Customer Wins in 2025 LIMERICK, Ireland, Feb. 25, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the fourth quarter and full year ended December 31, 2025. All dollar amounts are presented in Canadian dollars unless otherwise stated. Record Total Revenue: Fourth-quarter revenues increased by 24% to $17.0 mil...

 PRESS RELEASE

Global Pharmaceutical Packaging Manufacturer Selects Kneat

Global Pharmaceutical Packaging Manufacturer Selects Kneat LIMERICK, Ireland, Feb. 19, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced it has signed a Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer. This new customer operates more than 45 manufacturing facilities worldwide, including over a dozen GMP-regulated sites, and employs over 13,000 people across the United States, Europe, Asia, and South America. Under th...

 PRESS RELEASE

Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results F...

Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results February 25, 2026 LIMERICK, Ireland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI, OTCQX: KSIOF) (“Kneat” or the “Company”), a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the quarter ended December 31, 2025, after TSX market close on February 25, 2026. Eddie Ryan, Chief Executive Officer and Dave O’Reilly, Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on Febru...

 PRESS RELEASE

Global Biopharma Solutions Leader Selects Kneat to Drive Digital Valid...

Global Biopharma Solutions Leader Selects Kneat to Drive Digital Validation Excellence LIMERICK, Ireland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced a Master Services Agreement with one of the world’s leading providers of biopharma research and manufacturing technologies (“the Company”). Headquartered in Europe and operating across more than 60 global locations, this 13,000+ employee organization will begin deploying Kneat’s platform for equipment validation at severa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch